- Home
- DMRC vs ARCT Comparison
DMRC vs ARCT Comparison
Compare DMRC & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMRC
- ARCT
- Stock Information
- Founded
- DMRC 2008
- ARCT 2013
- Country
- DMRC United States
- ARCT United States
- Employees
- DMRC N/A
- ARCT N/A
- Industry
- DMRC EDP Services
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- DMRC Technology
- ARCT Health Care
- Exchange
- DMRC Nasdaq
- ARCT Nasdaq
- Market Cap
- DMRC 290.7M
- ARCT 298.3M
- IPO Year
- DMRC N/A
- ARCT N/A
- Fundamental
- Price
- DMRC $13.16
- ARCT $12.81
- Analyst Decision
- DMRC Strong Buy
- ARCT Strong Buy
- Analyst Count
- DMRC 1
- ARCT 8
- Target Price
- DMRC $30.00
- ARCT $52.33
- AVG Volume (30 Days)
- DMRC 204.0K
- ARCT 464.1K
- Earning Date
- DMRC 05-05-2025
- ARCT 05-12-2025
- Dividend Yield
- DMRC N/A
- ARCT N/A
- EPS Growth
- DMRC N/A
- ARCT N/A
- EPS
- DMRC N/A
- ARCT N/A
- Revenue
- DMRC $37,848,000.00
- ARCT $143,680,000.00
- Revenue This Year
- DMRC N/A
- ARCT N/A
- Revenue Next Year
- DMRC $11.24
- ARCT $42.36
- P/E Ratio
- DMRC N/A
- ARCT N/A
- Revenue Growth
- DMRC 2.44
- ARCT 15.38
- 52 Week Low
- DMRC $10.44
- ARCT $8.04
- 52 Week High
- DMRC $48.32
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- DMRC 50.14
- ARCT 56.34
- Support Level
- DMRC $12.64
- ARCT $11.51
- Resistance Level
- DMRC $13.29
- ARCT $13.00
- Average True Range (ATR)
- DMRC 0.54
- ARCT 1.01
- MACD
- DMRC 0.06
- ARCT 0.09
- Stochastic Oscillator
- DMRC 64.63
- ARCT 66.07
About DMRC Digimarc Corporation
Digimarc Corp is engaged in digital watermarking technologies. The Digimarc Illuminate platform is a distinctive software as a service (SaaS) cloud-based platform for digital connectivity that provides the tools for the application of digital watermarks and dynamic Quick Response (QR) codes, software (digital twins) that enables various systems and devices to interact with those data carriers and a centralized platform for capturing insights about digital interactions and automating activities based on that information. The company generates revenue through commercial and government applications of its technology. The company derives its revenue from software development services, subscriptions for products and related services, and licensing of patents.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.